145 related articles for article (PubMed ID: 36225810)
1. Arrhythmogenic right-ventricular cardiomyopathy with plakophilin-2 genetic variant concomitant with early manifestation of ventricular tachyarrhythmia: a case series.
Kawano K; Kondo H; Takahashi M; Shinohara T; Ohno S; Horie M; Takahashi N
Eur Heart J Case Rep; 2022 Oct; 6(10):ytac397. PubMed ID: 36225810
[TBL] [Abstract][Full Text] [Related]
2. Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
Cerrone M; Marrón-Liñares GM; van Opbergen CJM; Costa S; Bourfiss M; Pérez-Hernández M; Schlamp F; Sanchis-Gomar F; Malkani K; Drenkova K; Zhang M; Lin X; Heguy A; Velthuis BK; Prakken NHJ; LaGerche A; Calkins H; James CA; Te Riele ASJM; Delmar M
Eur Heart J; 2022 Mar; 43(12):1251-1264. PubMed ID: 34932122
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Genetic Characteristics of Arrhythmogenic Right Ventricular Cardiomyopathy Patients: A Single-Center Experience.
Al-Ghamdi BS; Alhadeq F; Alqahtani A; Alruwaili N; Rababh M; Alghamdi S; Almanea W; Alhassnan Z
Cardiol Res; 2023 Oct; 14(5):379-386. PubMed ID: 37936624
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
Yin K; Ding L; Li Y; Hua W
Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmogenic Right Ventricular Cardiomyopathy - 4 Swedish families with an associated PKP2 c.2146-1G>C variant.
Svensson A; Åström-Aneq M; Widlund KF; Fluur C; Green A; Rehnberg M; Gunnarsson C
Am J Cardiovasc Dis; 2016; 6(2):55-65. PubMed ID: 27335691
[TBL] [Abstract][Full Text] [Related]
7. Late presentation of arrhythmogenic right ventricular cardiomyopathy in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene: a case report.
Adachi Y; Hayashi T; Mitsuhashi T; Sakakura K; Yamada Y; Wada Y; Horie M; Momomura SI; Fujita H
BMC Cardiovasc Disord; 2019 Feb; 19(1):41. PubMed ID: 30782136
[TBL] [Abstract][Full Text] [Related]
8. Plakophilin-2 Truncation Variants in Patients Clinically Diagnosed With Catecholaminergic Polymorphic Ventricular Tachycardia and Decedents With Exercise-Associated Autopsy Negative Sudden Unexplained Death in the Young.
Tester DJ; Ackerman JP; Giudicessi JR; Ackerman NC; Cerrone M; Delmar M; Ackerman MJ
JACC Clin Electrophysiol; 2019 Jan; 5(1):120-127. PubMed ID: 30678776
[TBL] [Abstract][Full Text] [Related]
9. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
Calkins H; Corrado D; Marcus F
Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215
[TBL] [Abstract][Full Text] [Related]
10. AAV9:PKP2 improves heart function and survival in a Pkp2-deficient mouse model of arrhythmogenic right ventricular cardiomyopathy.
Wu I; Zeng A; Greer-Short A; Aycinena JA; Tefera AE; Shenwai R; Farshidfar F; Van Pell M; Xu E; Reid C; Rodriguez N; Lim B; Chung TW; Woods J; Scott A; Jones S; Dee-Hoskins C; Gutierrez CG; Madariaga J; Robinson K; Hatter Y; Butler R; Steltzer S; Ho J; Priest JR; Song X; Jing F; Green K; Ivey KN; Hoey T; Yang J; Yang ZJ
Commun Med (Lond); 2024 Mar; 4(1):38. PubMed ID: 38499690
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters.
Otterspoor LC; Reichert CL; Cramer MJ; Bhuiyan ZA; Wilde AA; Hauer RN
Neth Heart J; 2007; 15(10):348-53. PubMed ID: 18167567
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies.
Corrado D; Basso C; Nava A; Thiene G
Cardiol Rev; 2001; 9(5):259-65. PubMed ID: 11520449
[TBL] [Abstract][Full Text] [Related]
13. Biventricular Arrhythmogenic Cardiomyopathy Associated with a Novel Heterozygous
Çimen T; Wilzeck VC; Montrasio G; Bonetti NR; Medeiros-Domingo A; Grebmer C; Matter CM; Tanner FC; Manka R; Brunckhorst CB; Duru F; Saguner AM
J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556128
[TBL] [Abstract][Full Text] [Related]
14. Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients.
Al-Ghamdi B; Mallawi Y; Shafquat A; AlRuwaili N; Alhazaymeh A; Al-Manea W; Al-Fayyadh M
Cardiol Res; 2018 Aug; 9(4):204-214. PubMed ID: 30116448
[TBL] [Abstract][Full Text] [Related]
15. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
[TBL] [Abstract][Full Text] [Related]
17. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
[TBL] [Abstract][Full Text] [Related]
18. Genetic Variant Score and Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Plakophilin-2 Mutation Carriers.
Svensson A; Platonov PG; Haugaa KH; Zareba W; Jensen HK; Bundgaard H; Gilljam T; Madsen T; Hansen J; Dejgaard LA; Karlsson LO; Gréen A; Polonsky B; Edvardsen T; Svendsen JH; Gunnarsson C
Cardiology; 2021; 146(6):763-771. PubMed ID: 34469894
[TBL] [Abstract][Full Text] [Related]
19. Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria.
Costa S; Medeiros-Domingo A; Gasperetti A; Akdis D; Berger W; James CA; Ruschitzka F; Brunckhorst CB; Duru F; Saguner AM
Circ Genom Precis Med; 2021 Feb; 14(1):e003047. PubMed ID: 33232181
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous ICD Implantation and Catheter Ablation: A Step-Planned Approach for Ventricular Tachycardia Management in ARVC.
Sanniti A; Zagari D; Renzullo E; Valeriano C; Moretti P; Spadacini G; Tritto M
JACC Case Rep; 2022 Feb; 4(4):185-191. PubMed ID: 35199014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
